Baker Tilly Wealth Management LLC recently cut its stake in AbbVie Inc. by 3.5%, selling 169 shares in the second quarter. This downward adjustment, disclosed in the firm’s Form 13F filing, leaves the institutional investor with 4,602 shares.

Baker Tilly Wealth Management LLC recently pared down its holdings in Freeport-McMoRan Inc., selling 736 shares during the second quarter. The total stake now stands at 20,434 shares, valued at $886,000, reflecting a 3.5% decrease in the firm’s position.